Michael Liguori is a highly accomplished Principal Toxicologist at AbbVie, where he leverages over 30 years of extensive experience in the pharmaceutical and medical device industries. As a board-certified toxicologist (DABT) and biochemist, Michael plays a pivotal role in coordinating advanced toxicology studies within AbbVie's...
Michael Liguori is a highly accomplished Principal Toxicologist at AbbVie, where he leverages over 30 years of extensive experience in the pharmaceutical and medical device industries. As a board-certified toxicologist (DABT) and biochemist, Michael plays a pivotal role in coordinating advanced toxicology studies within AbbVie's Pre-clinical Safety organization. His expertise encompasses a broad spectrum of toxicological assessments, including both short-term and chronic studies, as well as Developmental and Reproductive Toxicology (DART) studies for cutting-edge drug candidates.
In his current position, Michael serves as the internal study director for toxicology studies across multiple species, ensuring that each study is meticulously designed and executed to meet regulatory standards and scientific rigor. He collaborates closely with project representatives to tailor study designs that align with the specific needs of each drug candidate, facilitating the generation of comprehensive reports that communicate critical findings to stakeholders. His adeptness in toxicology, combined with a solid foundation in biochemistry, cell culture, and organic chemistry, enables him to navigate complex challenges in drug discovery and development.
Michael's leadership skills are instrumental in guiding cross-functional teams through the intricacies of toxicological evaluation, fostering an environment of collaboration and innovation. His proficiency in virology and tissue culture further enhances his ability to assess the safety profiles of new therapeutic agents. As a key contributor to AbbVie's mission of advancing healthcare solutions, Michael Liguori exemplifies the integration of scientific expertise and strategic oversight in the pursuit of safe and effective medical advancements.
